PAR-19-315 - Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)
is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Special Interest: Biomarker Discover and Validation in Functional Neurological Disorders |
NOT-NS-22-010 |
NINDS
|
Oct 1, 2021 |
Jan 8, 2025
|
R61/R33, U01, U44 |
Expired NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Special Interest (NOSI) in Migraine and Headache Research |
NOT-NS-22-051 |
NINDS
|
Dec 27, 2021 |
May 8, 2022
|
U01, K01, UG3/UH3, K22, K99/R00, K02, K08, R01, F30, K23, F32, R21, F31, R61/R33 |
Notice of Special Interest (NOSI) in NINDS mission relevant Pain Research |
NOT-NS-22-050 |
NINDS
|
Dec 27, 2021 |
May 8, 2022
|
K01, UG3/UH3, K99/R00, K22, K08, R01, K02, F30, K23, R21, F32, F31, U01, U24, R61/R33 |
|